CMO: Hungary's medicines authority grants licences for two more vaccines
Hungary's medicines authority OGYÉI has granted licences for use to the Chinese CanSino coronavirus vaccine and Covishield, AstraZeneca's vaccine produced in India.
Chief Medical Officer Cecília Müller said Hungary's medicines authority OGYÉI has granted licences for use to the Chinese CanSino coronavirus vaccine and Covishield, AstraZeneca's vaccine produced in India.
According to MTI, Müller said she hoped that a greater choice of vaccines would bolster the country’s vaccination program, adding that “the jab is the only way out of the epidemic”. She said that 1.59 million Hungarians, 16 percent of the population, had received at least their first shot, but warned that the third wave of the pandemic was “still extremely dynamic”, with the highly infectious British coronavirus variant causing 90 percent of the new cases. “We’re running a race against time; the more immunised people we have, the sooner the epidemic will subside,” she said, encouraging citizens to “accept the vaccine offered without further consideration”.
Müller added that the highest number of hospitalised Covid-patients, 625 people, are being treated in the hospitals of Budapest’s Semmelweis University, while another 450 were in the city’s Honvéd hospital.
Photo credit: koronavirus.gov.hu